Healthcare101

Therapeutic Drug Monitoring Market in terms of revenue was estimated to be worth $1.8 billion in 2022 and is poised to reach $2.9 billion by 2027, growing at a CAGR of 9.6% from 2022 to 2027 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by the Increasing incidence of chronic and infectious diseases and growing awareness about early disease diagnosis. However, Alternatives to conventional TDM may challenge the growth of this market. Attractive Opp...

The viral vector manufacturing industry is poised for significant growth and innovation in the near future. As gene therapy and vaccine development continue to advance, the demand for viral vectors, which serve as delivery vehicles for therapeutic genes or vaccine antigens, is expected to rise. In response, the industry is focusing on optimizing manufacturing processes to meet the increasing demand for high-quality viral vectors. Advanced technologies, such as suspension cell culture systems, si...

Ultrasound Market in terms of revenue was estimated to be worth $8.5 billion in 2023 and is poised to reach $11.6 billion by 2028, growing at a CAGR of 6.3% from 2023 to 2028 according to a new report by MarketsandMarkets™. The major factors driving the growth of this market include rising patient population, various chronic diseases, and technological advancements along with the increasing adoption of ultrasound for diagnostic imaging. Download an Illustrative overview: https://www.ma...

Pen Needles Market in terms of revenue was estimated to be worth $1.6 Billion in 2023 and is poised to reach $2.5 Billion by 2028, growing at a CAGR of 9.1% from 2023 to 2028 according to a new report by MarketsandMarkets™. The increasing healthcare expenditure on diabetes care, and mandates pertaining to safety pen needles are some factors that provide lucrative opportunities for key players in the market. However, reuse and misuse of pen injectors, and factors such as needles anxiety and pr...

The Global Urology Devices Market in terms of revenue was estimated to be worth $38.0 billion in 2021 and is poised to reach $46.4 billion by 2026, growing at a CAGR of 4.1% from 2021 to 2026. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Investments by hospitals for procuring advanced instrum...

According to the new market research report "Prefilled Syringes Market by Type [Conventional (Disposable, Reusable), Safety], Material (Glass, Plastic), Design (Single-Chamber, Dual-Chamber, Customized), Application (Diabetes, Cancer, Arthritis, Anaphylaxis, Ophthalmology) - Global Forecast to 2025", published by MarketsandMarkets™, is estimated to be USD 5.6 billion in 2020 and projected to reach USD 8.6 billion by 2025, at a CAGR of 9.0%. The Rising target disease population, rapid growth in g...

The Global Rehabilitation Equipment Market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. The growth of this market is primarily driven by the increasing prevalence of chronic diseases such as arthritis and cancer, requiring rehabilitation therapies, high risk of injuries to caregivers during the manual handling of patients, rising geriatric and obese populations, and increasing demand for rehabilitation therapies owing...

The Global Wearable Injectors Market in terms of revenue was estimated to be worth $7.2 billion in 2021 and is poised to reach $11.5 billion by 2026, growing at a CAGR of 9.9% from 2021 to 2026. The current edition of the report consists of an updated market overview, average selling price trends, value chain analysis, Porter’s Five Forces analysis, ecosystem map, pricing analysis, patent analysis, and new industry insights. The growth of this market is primarily driven by the rising prevalence ...

The Global Viral Vector Manufacturing Market in terms of revenue was estimated to be worth $5.5 billion in 2023 and is poised to reach $12.8 billion by 2028, growing at a CAGR of 18.2% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth of this market is majorly driven ...

The Global Rapid Microbiology Testing Market in terms of revenue was estimated to be worth $4.2 billion in 2021 and is poised to reach $6.7 billion by 2026, growing at a CAGR of 9.4% from 2021 to 2026. The new research study consists of an industry trend analysis of the market. The stakeholders and consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Market growth is driven by the growing incidence...

In the near future, the humanized mouse and rat model industry is set to undergo transformative advancements, revolutionizing biomedical research and drug development. These cutting-edge models, where mice and rats are genetically modified to possess human-like characteristics and immune systems, will play a pivotal role in bridging the gap between preclinical studies and clinical trials. Through refined genetic engineering techniques, these models will closely mimic human physiology, enabling m...

Laboratory Information Management System (LIMS) Market in terms of revenue was estimated to be worth $1.6 billion in 2023 and is poised to reach $3.3 billion by 2028, growing at a CAGR of 14.6% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growing popularity of cloud-based LIMS, use of LIMS in cannabis industry, significant growth potential in emerging markets are some of the key factors that offer opportunities to the market during the forecast period. However, the dear...

The Global Laboratory Information Management Systems Market is projected to reach USD 3.3 billion by 2028 from USD 1.6 billion in 2023, at a CAGR of 14.6% during the forecast period. The significant growth potential in emerging markets such as China, India, Japan, Singapore, Brazil, and Middle Eastern countries, growing popularity of cloud-based LIMS pertaining to large volumes of data generated in laboratories & reduced total cost of ownership of laboratory informatics solutions are some of the...

The Global Bronchoscopy Market in terms of revenue was estimated to be worth $2.5 billion in 2022 and is poised to reach $3.7 billion by 2027, growing at a CAGR of 7.9% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Market growth is largely driven by the rising prevalence of ...

The Global Rehabilitation Equipment Market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. The growth of this market is primarily driven by the increasing prevalence of chronic diseases such as arthritis and cancer, requiring rehabilitation therapies, high risk of injuries to caregivers during the manual handling of patients, rising geriatric and obese populations, and increasing demand for rehabilitation therapies owing...

According to the new market research report “Veterinary Equipment and Supplies Market by Type (Consumables, Patient Monitors, Anesthesia, Infusion Pumps), Application (Surgical (Gynecology, Dental), Diagnosis), Animal (Companion, Bovines), End User (Hospitals, Clinics) - Global Forecast to 2027”, published by MarketsandMarkets™, the global veterinary equipment market is projected to reach USD 2.9 Billion by 2027 from USD 2.0 Billion in 2022, at a CAGR of 8.1% during the forecast period. The Risi...

The Pen Needles Market is expected to reach USD 2.2 Billion by 2026 from an estimated USD 1.3 billion in 2021, at a CAGR of 11.2%. Growth in the market is largely driven by the growing prevalence of chronic diseases and the favourable reimbursement scenario in selected countries. On the other hand, the preference for alternative modes of drug delivery, poor reimbursement in developing countries, and needle anxiety are expected to restrain the overall market growth. Misuse of insulin pens and reu...